HeartSciences Inc. (HSCS)Healthcare | Medical Devices | Southlake, United States | NasdaqCM
2.15 USD
+0.10
(4.873%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 2.14 -0.01 (-0.010%) ⇩ (April 17, 2026, 4:12 p.m. EDT) Short-term: ★☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 2:57 p.m. EDT
HeartSciences Inc. (HSCS) appears to be in a highly volatile and weak position based on its recent price history and fundamental metrics. The stock has been trading below its 52-week low and is currently at $2.08, which is close to its 52-week low of $2.01. The recent price movements show a downward trend, with the 50-day average and 200-day average both indicating a negative change. The stock's forward PE and trailing EPS are negative, suggesting financial distress and poor earnings performance. Additionally, the stock has a high debt-to-equity ratio and negative operating margins, indicating significant financial risk. The lack of recent dividends and the negative fundamentals make it a poor candidate for both short-term and long-term investments. The forecasting model's low p-values and high H-Stat suggest that the model's predictions may not be reliable. Overall, the stock is not a good investment at this time. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.108228 |
| MSTL | 0.252095 |
| AutoETS | 0.264823 |
| AutoTheta | 0.273396 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 30.96 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.269 |
| Excess Kurtosis | -0.91 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 145.813 |
| Revenue per Share | 0.004 |
| Market Cap | 6,846,786 |
| Forward P/E | -0.76 |
| Beta | 2.45 |
| Previous Name | Heart Test Laboratories, Inc. |
| Website | https://heartsciences.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.35625 |
| Address1 | 550 Reserve Street |
| Address2 | Suite 360 |
| All Time High | 600.0 |
| All Time Low | 1.89 |
| Ask | 2.16 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 14,310 |
| Average Daily Volume3 Month | 16,695 |
| Average Volume | 16,695 |
| Average Volume10Days | 14,310 |
| Beta | 2.452 |
| Bid | 3.29 |
| Bid Size | 1 |
| Book Value | 0.833 |
| City | Southlake |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.1499 |
| Current Ratio | 1.194 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 2.1501 |
| Day Low | 2.03 |
| Debt To Equity | 145.813 |
| Display Name | HeartSciences |
| Ebitda | -7,768,315 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.942 |
| Enterprise To Revenue | 844.134 |
| Enterprise Value | 7,317,799 |
| Eps Current Year | -3.375 |
| Eps Forward | -2.825 |
| Eps Trailing Twelve Months | -4.49 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.59324 |
| Fifty Day Average Change | -0.44334006 |
| Fifty Day Average Change Percent | -0.1709599 |
| Fifty Two Week Change Percent | -35.625 |
| Fifty Two Week High | 6.47 |
| Fifty Two Week High Change | -4.3201 |
| Fifty Two Week High Change Percent | -0.6677125 |
| Fifty Two Week Low | 1.89 |
| Fifty Two Week Low Change | 0.25989997 |
| Fifty Two Week Low Change Percent | 0.13751322 |
| Fifty Two Week Range | 1.89 - 6.47 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,655,386,200,000 |
| Float Shares | 3,070,529 |
| Forward Eps | -2.825 |
| Forward P E | -0.7610265 |
| Free Cashflow | -4,213,324 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 15 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.57919 |
| Gross Profits | 5,021 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.02342 |
| Held Percent Institutions | 0.062119998 |
| Implied Shares Outstanding | 3,184,700 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,022-06-15 |
| Language | en-US |
| Last Fiscal Year End | 1,745,971,200 |
| Last Split Date | 1,715,904,000 |
| Last Split Factor | 1:100 |
| Long Business Summary | HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas. |
| Long Name | HeartSciences Inc. |
| Market | us_market |
| Market Cap | 6,846,786 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_51732680 |
| Most Recent Quarter | 1,769,817,600 |
| Name Change Date | 2,026-04-16 |
| Net Income To Common | -8,485,301 |
| Next Fiscal Year End | 1,777,507,200 |
| Non Diluted Market Cap | 6,846,786 |
| Number Of Analyst Opinions | 2 |
| Open | 2.07 |
| Operating Cashflow | -7,340,799 |
| Operating Margins | -899.3956 |
| Payout Ratio | 0.0 |
| Phone | 682 237 7781 |
| Post Market Change | -0.009899855 |
| Post Market Change Percent | -0.4604798 |
| Post Market Price | 2.14 |
| Post Market Time | 1,776,456,738 |
| Prev Name | Heart Test Laboratories, Inc. |
| Previous Close | 2.05 |
| Price Eps Current Year | -0.6370074 |
| Price Hint | 4 |
| Price To Book | 2.5809124 |
| Price To Sales Trailing12 Months | 789.80115 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.796 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.09990001 |
| Regular Market Change Percent | 4.873171 |
| Regular Market Day High | 2.1501 |
| Regular Market Day Low | 2.03 |
| Regular Market Day Range | 2.03 - 2.1501 |
| Regular Market Open | 2.07 |
| Regular Market Previous Close | 2.05 |
| Regular Market Price | 2.1499 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 19,402 |
| Return On Assets | -0.73509 |
| Return On Equity | -3.82323 |
| Revenue Per Share | 0.004 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 3,184,700 |
| Shares Percent Shares Out | 0.0111 |
| Shares Short | 35,192 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 37,981 |
| Short Name | HeartSciences Inc. |
| Short Percent Of Float | 0.0113 |
| Short Ratio | 3.41 |
| Source Interval | 15 |
| State | TX |
| Symbol | HSCS |
| Target High Price | 12.0 |
| Target Low Price | 8.0 |
| Target Mean Price | 10.0 |
| Target Median Price | 10.0 |
| Total Cash | 3,397,035 |
| Total Cash Per Share | 1.067 |
| Total Debt | 3,867,131 |
| Total Revenue | 8,669 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -4.49 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.120705 |
| Two Hundred Day Average Change | -0.9708049 |
| Two Hundred Day Average Change Percent | -0.31108513 |
| Type Disp | Equity |
| Volume | 19,402 |
| Website | https://heartsciences.com |
| Zip | 76,092 |